Resveratrol Protects SAMP8 Brain Under Metabolic Stress: Focus on Mitochondrial Function and Wnt Pathway

Molecular Neurobiology

Volumn 54, Issue 3, 2017, Pages 1661-1676

  Palomera Avalos, V ^a   Grinan Ferre C ^a   Puigoriol Ilamola, D ^a   Camins, A ^a   Sanfeliu, C ^b   Canudas, A M ^a   Pallas M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

Aging; Behavior; Cognition; Diabetes metabolic stress; Fission; Fusion; Learning; Mitochondria; Mitochondrial dynamics; Neurodegeneration; Resveratrol; catenin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENYLATE KINASE; BETA CATENIN; CELL PROTEIN; CYTOCHROME C OXIDASE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 6; MITOFUSIN 2; MTCQ1 CYTOCHROME C OXIDASE SUBUNIT I; OPTIC ATROPHY 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PORIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE [UBIQUINONE] 1BETA SUBCOMPLEX SUBUNIT 8; RESVERATROL; SERINE; SUCCINATE DEHYDROGENASE; TAU PROTEIN; TUMOR NECROSIS FACTOR; TYROSINE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; WNT PROTEIN; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CELL COUNT; CELL FUNCTION; CELL STRUCTURE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIPPOCAMPUS; LIPID DIET; MALE; METABOLIC STRESS; MITOCHONDRIAL FUNCTION; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TRANSMISSION ELECTRON MICROSCOPY; WNT SIGNALING PATHWAY; ANIMAL; BRAIN; CELL AGING; DRUG EFFECTS; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RANDOMIZATION; WNT SIGNALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CELLULAR SENESCENCE; DIET, HIGH-FAT; MALE; MICE; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; STILBENES; STRESS, PHYSIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 84957967202     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9770-0     Document Type: Article

References (67)

1. Nilsson LG (2003) Memory function in normal aging. Acta Neurol Scand 107(Suppl 179):7–13
2. Niccoli T, Partridge L (2012) Ageing as a risk factor for disease. Curr Biol 1122(17):R741–R752
3. Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, Castellano A, Pifferi F et al (2011) Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 27:3–20
4. Hoyer S (1993) Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer’s disease: a speculative synthesis. J Geriatr Psychiatry Neurol 6(1):3–13
5. Hoyer S (1996) Oxidative metabolism deficiencies in brains of patients with Alzheimer’s disease. Acta Neurol Scand Suppl 165:18–24
6. Bobba A, Amadoro G, Valenti D, Corsetti V, Lassandro R, Atlante A (2013) Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through complex I-dependent ROS production, respectively. Mitochondrion 13(4):298–311
7. Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA et al (1998) Alzheimer’s disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105(4–5):439–461
8. Segobin S, La Joie R, Ritz L, Beaunieux H, Desgranges B, Chételat G, Pitel AL, Eustache F (2015) FDG-PET contributions to the pathophysiology of memory impairment. Neuropsychol Rev 25(3):326–355
9. Rapoport SI, Hatanpää K, Brady DR, Chandrasekaran K (1996) Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer Disease. Neurodegeneration 5(4):473–476
10. Kwon B, Gamache T, Lee HK, Querfurth HW (2015) Synergistic effects of β-amyloid and ceramide-induced insulin resistance on mitochondrial metabolism in neuronal cells. Biochim Biophys Acta 1852(9):1810–1823
11. Petrov D, Pedrós I, Artiach G, Sureda FX, Barroso E, Pallàs M, Casadesús G, Beas-Zarate C et al (2015) High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiencies contribute to Alzheimer disease pathology in rodents. Biochim Biophys Acta 1852(9):1687–1699
12. Reddy PH, Beal FM (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol Med 14:45–53
13. Pulliam DA, Deepa SS, Liu Y, Hill S, Lin AL, Bhattacharya A, Shi Y, Sloane L et al (2014) Complex IV-deficient Surf1 (−/−) mice initiate mitochondrial stress responses. Biochem J 462(2):359–371
14. Coskun PE, Beal MF, Wallace DC (2004) Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A 101(29):10726–10731
15. Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF (2002) High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer’s disease brain. Hum Mol Genet 11(2):133–145
16. Onyango IG, Lu J, Rodova M, Lezi E, Crafter AB, Swerdlow RH (2010) Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim Biophys Acta 1802:228–234
17. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105:19318–19323
18. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci 29(28):9090–9103
19. Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta 1842(8):1240–1247
20. Westermann B (2012) Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta 1817(10):1833–1838
21. Bereiter-Hahn J (2014) Mitochondrial dynamics in aging and disease. Prog Mol Biol Transl Sci 127:93–131
22. Hall AR, Burke N, Dongworth RK, Hausenloy DJ (2014) Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 171(8):1890–1906
23. Rao TP, Kühl M (2010) An updated overview on Wnt signaling pathways a prelude for more. Circ Res 106:1798–1806
24. Christodoulides C, Scarda A, Granzotto M, Milan G, Dalla-Nora E, Keogh J, De Pergola G, Stirling H et al (2006) Wnt 10B mutations in human obesity. Diabetologia 49:678–684
25. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38(3):320–323
26. Kanazawa A, Tsukada S, Sekine A, Tsunoda T, Takahashi A, Kashiwagi A, Tanaka Y, Babazono T et al (2004) Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. Am J Hum Genet 75:832–843
27. Oliva CA, Vargas JY, Inestrosa NC (2013) Wnts in adult brain: from synaptic plasticity to cognitive deficiencies. Front Cell Neurosci 3(7):224
28. Inestrosa NC, Montecinos-Oliva C, Fuenzalida M (2012) Wnt signaling: role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmaco 7:788–807
29. Toledo EM, Inestrosa NC (2010) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer’s disease. Mol Psychiatry 15(272–285):228
30. Pallàs M, Porquet D, Vicente A, Sanfeliu C (2013) Resveratrol: new avenues for a natural compound in neuroprotection. Curr Pharm Des 19(38):6726–6731
31. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in Alzheimer’s disease. BMC Neurosci 9(Suppl 2):S6
32. Porquet D, Casadesús G, Bayod S, Vicente A, Canudas AM, Vilaplana J, Pelegrí C, Sanfeliu C et al (2013) Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8. Age 35(5):1851–1865
33. Porquet D, Griñán-Ferré C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pallàs M (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease. J Alzheimers Dis 42(4):1209–1220
34. Mehla J, Chauhan BC, Chauhan NB (2014) Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis 39(1):145–162
35. Ohta H, Nishikawa H, Hirai K, Kato K, Miyamoto M (1996) Relationship of impaired brain glucose metabolism to learning deficit in the senescence-accelerated mouse. Neurosci Lett 217(1):37–40
36. Morley JE, Farr SA, Kumar VB, Armbrecht HJ (2012) The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer’s disease. Curr Pharm 18(8):1123–1130
37. Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G (2008) From aging to Alzheimer’s disease: unveiling “the switch” with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15(4):615–624
38. Ayala JE, Samuel VT, Morton GJ, Obici S, Croniger CM, Shulman GI, Wasserman DH, McGuinness OP (2010) NIH Mouse Metabolic Phenotyping Center Consortium. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 3(9–10):525–534
39. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. Behavioral data. Behav Brain Res 31:47–59
40. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1(2):848–858
41. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
42. Hall CS (1934) Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 8(3):385–403
43. Crawley JN (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. Mental Retardation and Developmental Disabilities. Res Rev 10(4):248–258
44. Mayeda ER, Whitmer RA, Yaffe K (2015) Diabetes and cognition. Clin Geriatr Med 31(1):101–115
45. Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN et al (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and alzheimer’s disease. Mediators Inflamm. doi:10.1155/2015/105828
46. Baur JA, Ungvari Z, Minor RK, Le Couteur DG, de Cabo R (2012) Are sirtuins viable targets for improving health span and lifespan? Nat Rev Drug Discov 11(6):443–461
47. Minor RK, Baur JA, Gomes AP, Ward TM, Csiszar A, Mercken EM, Abdelmohsen K, Shin YK et al (2011) SRT1720 improves survival and healthspan of obese mice. Sci Rep 1:70
48. Julien C, Tremblay C, Phivilay A, Berthiaume L, Emond V, Julien P, Calon F (2010) High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 31:1516–1531
49. Currais A, Prior M, Lo D, Jolivalt C, Schubert D, Maher P (2012) Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell 11(6):1017–1026
50. López-Ramos JC, Jurado-Parras MT, Sanfeliu C, Acuña-Castroviejo D, Delgado-García JM (2012) Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence. Neurobiol Aging 33(3):627.e13–627.e26
51. Zhang L, Trushin S, Christensen TA, Bachmeier BV, Gateno B, Schroeder A, Yao J, Itoh K et al (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s disease. Sci Rep 5(6):18725
52. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J et al (2006) Elliott, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127:1109–1122
53. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L et al (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15(5):675–690
54. Menzies KJ, Singh K, Saleem A, Hood DA (2013) Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem 288(10):6968–6979
55. Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC (2011) Glucocorticoids and tumor necrosis factor (TNF) α increase oxidative stress and suppress WNT signaling in osteoblasts. J Biol Chem 286(52):44326–44335
56. Hiyama A, Yokoyama K, Nukaga T, Sakai D, Mochida J (2013) A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cells. Arthritis Res Ther 15(6):R189. doi:10.1186/ar4379
57. Stock M, Böhm C, Scholtysek C, Englbrecht M, Fürnrohr BG, Klinger P, Gelse K, Gayetskyy S et al (2013) Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis. Arthritis Rheum 65(9):2310–2322. doi:10.1002/art.38054
58. Arrázola MS, Silva-Álvarez C, Inestrosa NC (2015) How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario. Front Cell Neurosci 9:166
59. Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149(6):1192–1205
60. Bayod S, Felice P, Andrés P, Rosa P, Camins A, Pallàs M, Canudas AM (2015) Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice. Neurobiol Aging 36(2):720–729
61. Carter LG, D’Orazio JA, Pearson KJ (2014) Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 21:R209–R225
62. Hope C, Kestutis P, Marina P (2008) Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: Implications for colon cancer prevention. Mol Nutr Food Res 52(Suppl 1):S52–S61. doi:10.1002/mnfr.200700448
63. Takahashi-Yanaga F, Kahn M (2010) Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16:3153
64. Zhang P, Li H, Yang B (2014) Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer 5(5–6):154–164
65. Mo S, Cui Z (2012) Regulation of canonical Wnt signaling during development and diseases. Embryogenesis. Dr. Ken-Ichi Sato (Ed.), ISBN: 978-953-51-0466-7, InTech
66. Armbrecht HJ, Siddiqui AM, Green M, Farr SA, Kumar VB, Banks WA, Patrick P, Shah GN et al (2015) Antisense against Amyloid-β protein precursor reverses memory deficits and alters gene expression in neurotropic and insulin-signaling pathways in SAMP8 mice. J Alzheimers Dis 46(2):535–548
67. Griñan-Ferre C, Pérez-Cáceres D, Gutiérrez-Zetina SM, Camins A, Palomera-Avalos V, Ortuño-Sahagún D, Rodrigo MT, Pallás M (2015) Environmental enrichment improves behavior, cognition, and brain functional markers in young senescence-accelerated prone mice (SAMP8). Mol Neurobiol. doi:10.1007/s12035-015-9210-6